Abbott Laboratories, Inc. ABT recently secured the FDA’s approval for the TriClip transcatheter edge-to-edge repair (TEER) ...

Abt Sportsline introduces a new engine upgrade for twin-turbo 4.0-liter V8 Audi and Lamborghini models. Upgrades increase power as high as 840 horsepower and 737 lb-ft of torque in the Urus ...

Despite recent challenges, ABT's core business remains robust, with impressive performance in segments like Nutrition and Medical Devices. Looking for more investing ideas like this one?

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments ...

Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/B Growth Investor model based on the published strategy ...

Wednesday, Abbott Laboratories (NYSE:ABT) reported first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying base business, beating the consensus of $9.88 billion.

Good morning, and thank you for standing by. Welcome to Abbott's first-quarter 2024 earnings conference call. [Operator Instructions] This call is being recorded by Abbott. With the exception of ...